9:00 AM - 10:25 AM CST Saturday, January 16

Plenary Session III

During this session, we will explore the new hope for extending the indications for neuromodulation to new frontiers. In many cases, these breakthrough areas in neuromodulation are being funded by large investments by the NIH and other agencies. Key opinion leaders will review innovative new research and clinical trials being conducted in respiratory, and cardiac function.  

Read more...
10:45 AM - 11:45 AM CST Saturday, January 16

Keeping Up With the Dynamic Field of Neuromodulation: Mentoring, Educational and Teaching Techniques of the Future

Recent and ongoing developments and advances in the field of neuromodulation have been creating an active learning environment where information needs to be disseminated effectively and efficiently from the scientific discovery to clinical implementation. This session will emphasize the ever dynamic and evolving field of neuromodulation and how best to implement, teach, mentor, and guide practitioners, so practicing providers will be best equipped to improve outcomes for their patients.

Read more...
10:45 AM - 11:45 AM CST Saturday, January 16

Strategies to Personalize Invasive Neurostimulation Therapies

This session will present strategies and technologies to improve the personalization of invasive clinical neurostimulation technologies. It will focus on the widely-used clinical neurostimulation technologies, spinal cord stimulation (SCS), and deep brain stimulation (DBS). Technologies will include patient-specific computational modeling and functional neuroimaging with the goal to aid neural targeting and parameter optimization.

Read more...
10:45 AM - 11:45 AM CST Saturday, January 16

Neurostimulation in Epilepsy: Thinking Outside the Box

Neurostimulation is a growing part of the treatment algorithm at many comprehensive epilepsy centers. As we learn more about these technologies, many investigators are exploring novel stimulation paradigms and patient populations that may extend beyond the originally labeled indications. We are also reaching a better understanding of the direct and indirect effects of brain stimulation on seizures. Here we will discuss novel and innovative uses of neurostimulation for epilepsy, explore potential mechanisms of action, and discuss high-yield case presentations.

Read more...
10:45 AM - 11:45 AM CST Saturday, January 16

The Neurostimulation Appropriateness Consensus Committee (NACC) Guidelines: Update

The NACC Guidelines are authoritative international consensus-based practice guidelines to inform clinicians regarding the safe and effective practice of invasive neurostimulation. The NACC 2017 guidelines were divided into three major sections: bleeding risk, infection risk, and prevention of neurologic injury. NACC 2021 is currently convening and is in the process of updating the 2017 guidelines. This session will provide the latest updates on neuromodulation risk mitigation practices and strategies.

Read more...
Speaker:

Tim J. Lamer, MD

10:45 AM - 11:45 AM CST Saturday, January 16

Surgical Therapies for Psychiatric Diseases

Medication and therapeutic paradigms are continually advancing the treatment of psychiatric disease. Yet a large population of patients remains refractory to noninvasive treatments. Surgical therapies for treatment-resistant depression, obsessive-compulsive disorder, post-traumatic stress disorder, and others have an extended track record of efficacy, and are evolving along with our technological capabilities, such as minimally invasive neurostimulation (e.g., deep brain stimulation). These technical advances are paralleled by advances in machine learning applied to neuroimaging, electrophysiology, and behavioral biomarkers of disease. This session will introduce the attendee to the current state of the art in surgical therapies for psychiatric disease, highlighting deep brain stimulation, vagus nerve stimulation, and lesioning procedures.

Read more...
Subscribe to this RSS feed